News

The latest STOPCAP M1 results were presented at American Society of Clinical Oncology (ASCO) Meeting in Chicago, by Dr Claire Vale and Dr Susan Halabi   Claire Vale presented results of a meta-analysis of patient data from 2261 men with metastatic hormone sensitive prostate cancer (mHSPC) in 3 trials showed that on average, chemotherapy improved 5-year survival by 11% compare ...

The STOPCAP Team are participating in the second Movember-ICECaP webinar on Wednesday 4th May 2022

  Click below to read about our STOPCAP M1 activities over the last few months and also what is coming next.   October Newsletter ...

Our framework for prospective, adaptive meta-analysis of aggregate data (FAME) has now been published in PloS Medicine. Developed alongside our STOPCAP meta-analyses, FAME enables more timely, thorough, and reliable systematic reviews of aggregate data, and is only possible through collaboration with trials investigators. Now a similar prospective and collaborative approach is being used in the fight against COVID-19. 

The STOPCAP Team are participating in the inaugural Movember-ICECaP webinar on Wednesday 28th April 2021